Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG).
Crump, Michael
Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). [electronic resource] - Cancer Oct 2004 - 1835-42 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
0008-543X
10.1002/cncr.20587 doi
Administration, Oral
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cisplatin--therapeutic use
Deoxycytidine--analogs & derivatives
Dexamethasone--therapeutic use
Female
Humans
Infusions, Intravenous
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Salvage Therapy
Stem Cell Transplantation
Treatment Outcome
Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). [electronic resource] - Cancer Oct 2004 - 1835-42 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
0008-543X
10.1002/cncr.20587 doi
Administration, Oral
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cisplatin--therapeutic use
Deoxycytidine--analogs & derivatives
Dexamethasone--therapeutic use
Female
Humans
Infusions, Intravenous
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Salvage Therapy
Stem Cell Transplantation
Treatment Outcome